The global B Cell Maturation Antigen Targeted Therapy market was valued at million in 2024 and is projected to reach US$ million by 2032, at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
We have surveyed the B Cell Maturation Antigen Targeted Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for B Cell Maturation Antigen Targeted Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding B Cell Maturation Antigen Targeted Therapy. This report contains market size and forecasts of B Cell Maturation Antigen Targeted Therapy in global, including the following market information:
Global B Cell Maturation Antigen Targeted Therapy market revenue, 2020-2025, 2026-2032, ($ millions)
Global top five B Cell Maturation Antigen Targeted Therapy companies in 2024 (%)
Total Market by Segment:
Global B Cell Maturation Antigen Targeted Therapy market, by Type, 2020-2025, 2026-2032 ($ millions)
Global B Cell Maturation Antigen Targeted Therapy market segment percentages, by Type, 2024 (%)
Antibody-Drug Conjugates
CAR-T Cells and Bispecific T Cell Engagers
Global B Cell Maturation Antigen Targeted Therapy market, by Application, 2020-2025, 2026-2032 ($ millions)
Global B Cell Maturation Antigen Targeted Therapy market segment percentages, by Application, 2024 (%)
Hospitals
Clinics
Others
Global B Cell Maturation Antigen Targeted Therapy market, by region and country, 2020-2025, 2026-2032 ($ millions)
Global B Cell Maturation Antigen Targeted Therapy market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies B Cell Maturation Antigen Targeted Therapy revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies B Cell Maturation Antigen Targeted Therapy revenues share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Johnson & Johnson
Amgen
Seagen
AbbVie
Novartis
BioTherapeutics
Celgene
Bluebird Bio
Bristol Mayer Squibb
Carsgen Therapeutics
Juno Therapeutics
Cogent Bioscience
CRISPR Therapeutics
Allogene Therapeutics
Harpoon Therapeutics
Poseida Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of B Cell Maturation Antigen Targeted Therapy, market overview.
Chapter 2: Global B Cell Maturation Antigen Targeted Therapy market size in revenue.
Chapter 3: Detailed analysis of B Cell Maturation Antigen Targeted Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of B Cell Maturation Antigen Targeted Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 B Cell Maturation Antigen Targeted Therapy Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global B Cell Maturation Antigen Targeted Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global B Cell Maturation Antigen Targeted Therapy Overall Market Size
2.1 Global B Cell Maturation Antigen Targeted Therapy Market Size: 2024 VS 2032
2.2 Global B Cell Maturation Antigen Targeted Therapy Market Size, Prospects & Forecasts: 2020-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top B Cell Maturation Antigen Targeted Therapy Players in Global Market
3.2 Top Global B Cell Maturation Antigen Targeted Therapy Companies Ranked by Revenue
3.3 Global B Cell Maturation Antigen Targeted Therapy Revenue by Companies
3.4 Top 3 and Top 5 B Cell Maturation Antigen Targeted Therapy Companies in Global Market, by Revenue in 2024
3.5 Global Companies B Cell Maturation Antigen Targeted Therapy Product Type
3.6 Tier 1, Tier 2, and Tier 3 B Cell Maturation Antigen Targeted Therapy Players in Global Market
3.6.1 List of Global Tier 1 B Cell Maturation Antigen Targeted Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 B Cell Maturation Antigen Targeted Therapy Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global B Cell Maturation Antigen Targeted Therapy Market Size Markets, 2024 & 2032
4.1.2 Antibody-Drug Conjugates
4.1.3 CAR-T Cells and Bispecific T Cell Engagers
4.2 Segmentation by Type - Global B Cell Maturation Antigen Targeted Therapy Revenue & Forecasts
4.2.1 Segmentation by Type - Global B Cell Maturation Antigen Targeted Therapy Revenue, 2020-2025
4.2.2 Segmentation by Type - Global B Cell Maturation Antigen Targeted Therapy Revenue, 2026-2032
4.2.3 Segmentation by Type - Global B Cell Maturation Antigen Targeted Therapy Revenue Market Share, 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global B Cell Maturation Antigen Targeted Therapy Market Size, 2024 & 2032
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 Segmentation by Application - Global B Cell Maturation Antigen Targeted Therapy Revenue & Forecasts
5.2.1 Segmentation by Application - Global B Cell Maturation Antigen Targeted Therapy Revenue, 2020-2025
5.2.2 Segmentation by Application - Global B Cell Maturation Antigen Targeted Therapy Revenue, 2026-2032
5.2.3 Segmentation by Application - Global B Cell Maturation Antigen Targeted Therapy Revenue Market Share, 2020-2032
6 Sights by Region
6.1 By Region - Global B Cell Maturation Antigen Targeted Therapy Market Size, 2024 & 2032
6.2 By Region - Global B Cell Maturation Antigen Targeted Therapy Revenue & Forecasts
6.2.1 By Region - Global B Cell Maturation Antigen Targeted Therapy Revenue, 2020-2025
6.2.2 By Region - Global B Cell Maturation Antigen Targeted Therapy Revenue, 2026-2032
6.2.3 By Region - Global B Cell Maturation Antigen Targeted Therapy Revenue Market Share, 2020-2032
6.3 North America
6.3.1 By Country - North America B Cell Maturation Antigen Targeted Therapy Revenue, 2020-2032
6.3.2 United States B Cell Maturation Antigen Targeted Therapy Market Size, 2020-2032
6.3.3 Canada B Cell Maturation Antigen Targeted Therapy Market Size, 2020-2032
6.3.4 Mexico B Cell Maturation Antigen Targeted Therapy Market Size, 2020-2032
6.4 Europe
6.4.1 By Country - Europe B Cell Maturation Antigen Targeted Therapy Revenue, 2020-2032
6.4.2 Germany B Cell Maturation Antigen Targeted Therapy Market Size, 2020-2032
6.4.3 France B Cell Maturation Antigen Targeted Therapy Market Size, 2020-2032
6.4.4 U.K. B Cell Maturation Antigen Targeted Therapy Market Size, 2020-2032
6.4.5 Italy B Cell Maturation Antigen Targeted Therapy Market Size, 2020-2032
6.4.6 Russia B Cell Maturation Antigen Targeted Therapy Market Size, 2020-2032
6.4.7 Nordic Countries B Cell Maturation Antigen Targeted Therapy Market Size, 2020-2032
6.4.8 Benelux B Cell Maturation Antigen Targeted Therapy Market Size, 2020-2032
6.5 Asia
6.5.1 By Region - Asia B Cell Maturation Antigen Targeted Therapy Revenue, 2020-2032
6.5.2 China B Cell Maturation Antigen Targeted Therapy Market Size, 2020-2032
6.5.3 Japan B Cell Maturation Antigen Targeted Therapy Market Size, 2020-2032
6.5.4 South Korea B Cell Maturation Antigen Targeted Therapy Market Size, 2020-2032
6.5.5 Southeast Asia B Cell Maturation Antigen Targeted Therapy Market Size, 2020-2032
6.5.6 India B Cell Maturation Antigen Targeted Therapy Market Size, 2020-2032
6.6 South America
6.6.1 By Country - South America B Cell Maturation Antigen Targeted Therapy Revenue, 2020-2032
6.6.2 Brazil B Cell Maturation Antigen Targeted Therapy Market Size, 2020-2032
6.6.3 Argentina B Cell Maturation Antigen Targeted Therapy Market Size, 2020-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa B Cell Maturation Antigen Targeted Therapy Revenue, 2020-2032
6.7.2 Turkey B Cell Maturation Antigen Targeted Therapy Market Size, 2020-2032
6.7.3 Israel B Cell Maturation Antigen Targeted Therapy Market Size, 2020-2032
6.7.4 Saudi Arabia B Cell Maturation Antigen Targeted Therapy Market Size, 2020-2032
6.7.5 UAE B Cell Maturation Antigen Targeted Therapy Market Size, 2020-2032
7 Companies Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Corporate Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.1.4 GlaxoSmithKline B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2020-2025)
7.1.5 GlaxoSmithKline Key News & Latest Developments
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Corporate Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.2.4 Johnson & Johnson B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2020-2025)
7.2.5 Johnson & Johnson Key News & Latest Developments
7.3 Amgen
7.3.1 Amgen Corporate Summary
7.3.2 Amgen Business Overview
7.3.3 Amgen B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.3.4 Amgen B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2020-2025)
7.3.5 Amgen Key News & Latest Developments
7.4 Seagen
7.4.1 Seagen Corporate Summary
7.4.2 Seagen Business Overview
7.4.3 Seagen B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.4.4 Seagen B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2020-2025)
7.4.5 Seagen Key News & Latest Developments
7.5 AbbVie
7.5.1 AbbVie Corporate Summary
7.5.2 AbbVie Business Overview
7.5.3 AbbVie B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.5.4 AbbVie B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2020-2025)
7.5.5 AbbVie Key News & Latest Developments
7.6 Novartis
7.6.1 Novartis Corporate Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.6.4 Novartis B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2020-2025)
7.6.5 Novartis Key News & Latest Developments
7.7 BioTherapeutics
7.7.1 BioTherapeutics Corporate Summary
7.7.2 BioTherapeutics Business Overview
7.7.3 BioTherapeutics B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.7.4 BioTherapeutics B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2020-2025)
7.7.5 BioTherapeutics Key News & Latest Developments
7.8 Celgene
7.8.1 Celgene Corporate Summary
7.8.2 Celgene Business Overview
7.8.3 Celgene B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.8.4 Celgene B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2020-2025)
7.8.5 Celgene Key News & Latest Developments
7.9 Bluebird Bio
7.9.1 Bluebird Bio Corporate Summary
7.9.2 Bluebird Bio Business Overview
7.9.3 Bluebird Bio B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.9.4 Bluebird Bio B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2020-2025)
7.9.5 Bluebird Bio Key News & Latest Developments
7.10 Bristol Mayer Squibb
7.10.1 Bristol Mayer Squibb Corporate Summary
7.10.2 Bristol Mayer Squibb Business Overview
7.10.3 Bristol Mayer Squibb B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.10.4 Bristol Mayer Squibb B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2020-2025)
7.10.5 Bristol Mayer Squibb Key News & Latest Developments
7.11 Carsgen Therapeutics
7.11.1 Carsgen Therapeutics Corporate Summary
7.11.2 Carsgen Therapeutics Business Overview
7.11.3 Carsgen Therapeutics B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.11.4 Carsgen Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2020-2025)
7.11.5 Carsgen Therapeutics Key News & Latest Developments
7.12 Juno Therapeutics
7.12.1 Juno Therapeutics Corporate Summary
7.12.2 Juno Therapeutics Business Overview
7.12.3 Juno Therapeutics B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.12.4 Juno Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2020-2025)
7.12.5 Juno Therapeutics Key News & Latest Developments
7.13 Cogent Bioscience
7.13.1 Cogent Bioscience Corporate Summary
7.13.2 Cogent Bioscience Business Overview
7.13.3 Cogent Bioscience B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.13.4 Cogent Bioscience B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2020-2025)
7.13.5 Cogent Bioscience Key News & Latest Developments
7.14 CRISPR Therapeutics
7.14.1 CRISPR Therapeutics Corporate Summary
7.14.2 CRISPR Therapeutics Business Overview
7.14.3 CRISPR Therapeutics B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.14.4 CRISPR Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2020-2025)
7.14.5 CRISPR Therapeutics Key News & Latest Developments
7.15 Allogene Therapeutics
7.15.1 Allogene Therapeutics Corporate Summary
7.15.2 Allogene Therapeutics Business Overview
7.15.3 Allogene Therapeutics B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.15.4 Allogene Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2020-2025)
7.15.5 Allogene Therapeutics Key News & Latest Developments
7.16 Harpoon Therapeutics
7.16.1 Harpoon Therapeutics Corporate Summary
7.16.2 Harpoon Therapeutics Business Overview
7.16.3 Harpoon Therapeutics B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.16.4 Harpoon Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2020-2025)
7.16.5 Harpoon Therapeutics Key News & Latest Developments
7.17 Poseida Therapeutics
7.17.1 Poseida Therapeutics Corporate Summary
7.17.2 Poseida Therapeutics Business Overview
7.17.3 Poseida Therapeutics B Cell Maturation Antigen Targeted Therapy Major Product Offerings
7.17.4 Poseida Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue in Global Market (2020-2025)
7.17.5 Poseida Therapeutics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. B Cell Maturation Antigen Targeted Therapy Market Opportunities & Trends in Global Market
Table 2. B Cell Maturation Antigen Targeted Therapy Market Drivers in Global Market
Table 3. B Cell Maturation Antigen Targeted Therapy Market Restraints in Global Market
Table 4. Key Players of B Cell Maturation Antigen Targeted Therapy in Global Market
Table 5. Top B Cell Maturation Antigen Targeted Therapy Players in Global Market, Ranking by Revenue (2024)
Table 6. Global B Cell Maturation Antigen Targeted Therapy Revenue by Companies, (US$, Mn), 2020-2025
Table 7. Global B Cell Maturation Antigen Targeted Therapy Revenue Share by Companies, 2020-2025
Table 8. Global Companies B Cell Maturation Antigen Targeted Therapy Product Type
Table 9. List of Global Tier 1 B Cell Maturation Antigen Targeted Therapy Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 B Cell Maturation Antigen Targeted Therapy Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segmentation by Type � Global B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2024 & 2032
Table 12. Segmentation by Type - Global B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn), 2020-2025
Table 13. Segmentation by Type - Global B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn), 2026-2032
Table 14. Segmentation by Application� Global B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2024 & 2032
Table 15. Segmentation by Application - Global B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2020-2025
Table 16. Segmentation by Application - Global B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2026-2032
Table 17. By Region� Global B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2024 & 2032
Table 18. By Region - Global B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2020-2025
Table 19. By Region - Global B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2026-2032
Table 20. By Country - North America B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2020-2025
Table 21. By Country - North America B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2026-2032
Table 22. By Country - Europe B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2020-2025
Table 23. By Country - Europe B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Asia B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2020-2025
Table 25. By Region - Asia B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2026-2032
Table 26. By Country - South America B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2020-2025
Table 27. By Country - South America B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2026-2032
Table 28. By Country - Middle East & Africa B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2020-2025
Table 29. By Country - Middle East & Africa B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2026-2032
Table 30. GlaxoSmithKline Corporate Summary
Table 31. GlaxoSmithKline B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 32. GlaxoSmithKline B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn) & (2020-2025)
Table 33. GlaxoSmithKline Key News & Latest Developments
Table 34. Johnson & Johnson Corporate Summary
Table 35. Johnson & Johnson B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 36. Johnson & Johnson B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn) & (2020-2025)
Table 37. Johnson & Johnson Key News & Latest Developments
Table 38. Amgen Corporate Summary
Table 39. Amgen B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 40. Amgen B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn) & (2020-2025)
Table 41. Amgen Key News & Latest Developments
Table 42. Seagen Corporate Summary
Table 43. Seagen B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 44. Seagen B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn) & (2020-2025)
Table 45. Seagen Key News & Latest Developments
Table 46. AbbVie Corporate Summary
Table 47. AbbVie B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 48. AbbVie B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn) & (2020-2025)
Table 49. AbbVie Key News & Latest Developments
Table 50. Novartis Corporate Summary
Table 51. Novartis B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 52. Novartis B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn) & (2020-2025)
Table 53. Novartis Key News & Latest Developments
Table 54. BioTherapeutics Corporate Summary
Table 55. BioTherapeutics B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 56. BioTherapeutics B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn) & (2020-2025)
Table 57. BioTherapeutics Key News & Latest Developments
Table 58. Celgene Corporate Summary
Table 59. Celgene B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 60. Celgene B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn) & (2020-2025)
Table 61. Celgene Key News & Latest Developments
Table 62. Bluebird Bio Corporate Summary
Table 63. Bluebird Bio B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 64. Bluebird Bio B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn) & (2020-2025)
Table 65. Bluebird Bio Key News & Latest Developments
Table 66. Bristol Mayer Squibb Corporate Summary
Table 67. Bristol Mayer Squibb B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 68. Bristol Mayer Squibb B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn) & (2020-2025)
Table 69. Bristol Mayer Squibb Key News & Latest Developments
Table 70. Carsgen Therapeutics Corporate Summary
Table 71. Carsgen Therapeutics B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 72. Carsgen Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn) & (2020-2025)
Table 73. Carsgen Therapeutics Key News & Latest Developments
Table 74. Juno Therapeutics Corporate Summary
Table 75. Juno Therapeutics B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 76. Juno Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn) & (2020-2025)
Table 77. Juno Therapeutics Key News & Latest Developments
Table 78. Cogent Bioscience Corporate Summary
Table 79. Cogent Bioscience B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 80. Cogent Bioscience B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn) & (2020-2025)
Table 81. Cogent Bioscience Key News & Latest Developments
Table 82. CRISPR Therapeutics Corporate Summary
Table 83. CRISPR Therapeutics B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 84. CRISPR Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn) & (2020-2025)
Table 85. CRISPR Therapeutics Key News & Latest Developments
Table 86. Allogene Therapeutics Corporate Summary
Table 87. Allogene Therapeutics B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 88. Allogene Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn) & (2020-2025)
Table 89. Allogene Therapeutics Key News & Latest Developments
Table 90. Harpoon Therapeutics Corporate Summary
Table 91. Harpoon Therapeutics B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 92. Harpoon Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn) & (2020-2025)
Table 93. Harpoon Therapeutics Key News & Latest Developments
Table 94. Poseida Therapeutics Corporate Summary
Table 95. Poseida Therapeutics B Cell Maturation Antigen Targeted Therapy Product Offerings
Table 96. Poseida Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue (US$, Mn) & (2020-2025)
Table 97. Poseida Therapeutics Key News & Latest Developments
List of Figures
Figure 1. B Cell Maturation Antigen Targeted Therapy Product Picture
Figure 2. B Cell Maturation Antigen Targeted Therapy Segment by Type in 2024
Figure 3. B Cell Maturation Antigen Targeted Therapy Segment by Application in 2024
Figure 4. Global B Cell Maturation Antigen Targeted Therapy Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global B Cell Maturation Antigen Targeted Therapy Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global B Cell Maturation Antigen Targeted Therapy Revenue: 2020-2032 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by B Cell Maturation Antigen Targeted Therapy Revenue in 2024
Figure 9. Segmentation by Type � Global B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2024 & 2032
Figure 10. Segmentation by Type - Global B Cell Maturation Antigen Targeted Therapy Revenue Market Share, 2020-2032
Figure 11. Segmentation by Application � Global B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2024 & 2032
Figure 12. Segmentation by Application - Global B Cell Maturation Antigen Targeted Therapy Revenue Market Share, 2020-2032
Figure 13. By Region - Global B Cell Maturation Antigen Targeted Therapy Revenue Market Share, 2020-2032
Figure 14. By Country - North America B Cell Maturation Antigen Targeted Therapy Revenue Market Share, 2020-2032
Figure 15. United States B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2020-2032
Figure 16. Canada B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2020-2032
Figure 17. Mexico B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2020-2032
Figure 18. By Country - Europe B Cell Maturation Antigen Targeted Therapy Revenue Market Share, 2020-2032
Figure 19. Germany B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2020-2032
Figure 20. France B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2020-2032
Figure 21. U.K. B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2020-2032
Figure 22. Italy B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2020-2032
Figure 23. Russia B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2020-2032
Figure 24. Nordic Countries B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2020-2032
Figure 25. Benelux B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2020-2032
Figure 26. By Region - Asia B Cell Maturation Antigen Targeted Therapy Revenue Market Share, 2020-2032
Figure 27. China B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2020-2032
Figure 28. Japan B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2020-2032
Figure 29. South Korea B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2020-2032
Figure 30. Southeast Asia B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2020-2032
Figure 31. India B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2020-2032
Figure 32. By Country - South America B Cell Maturation Antigen Targeted Therapy Revenue Market Share, 2020-2032
Figure 33. Brazil B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2020-2032
Figure 34. Argentina B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2020-2032
Figure 35. By Country - Middle East & Africa B Cell Maturation Antigen Targeted Therapy Revenue Market Share, 2020-2032
Figure 36. Turkey B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2020-2032
Figure 37. Israel B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2020-2032
Figure 38. Saudi Arabia B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2020-2032
Figure 39. UAE B Cell Maturation Antigen Targeted Therapy Revenue, (US$, Mn), 2020-2032
Figure 40. GlaxoSmithKline B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 41. Johnson & Johnson B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 42. Amgen B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 43. Seagen B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 44. AbbVie B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 45. Novartis B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 46. BioTherapeutics B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 47. Celgene B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 48. Bluebird Bio B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 49. Bristol Mayer Squibb B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 50. Carsgen Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 51. Juno Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 52. Cogent Bioscience B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 53. CRISPR Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 54. Allogene Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 55. Harpoon Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 56. Poseida Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2020-2025)